References
Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457–9.
Siewert JR, Feith M, Werner M. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232:353–61.
Curtis NJ, Noble F, Bailey IS, et al. The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. J Surg Oncol. 2014;109:202–7.
Siewert JR, Feith M. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer. J Am Coll Surg. 2007;205:s49–53.
Rusch VW. Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several? Semin Oncol. 2004;31:444–9.
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.
Macdonald JS, Stephen S, Malley RS, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.
van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.
Burkhard H, von Rhaden A, Feith M, et al. Carcinoma of the cardia: classification as esophageal or gastric cancer? Int J Colorectal Dis. 2005;20:89–93.
Rice TW, Blackstone EH, Rusch WV. 7th Edition of the AJCC cancer staging manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17:1721–4.
Buas MF, Vaughn TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013;23:3–9.
Burke EC, Karpeh MS, Conlon KC, et al. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997;225(3):262–7.
Power DG, Shatner MA, Gerdes H, et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg. 2009;208(2):173–8.
Bentrem DJ, Wilton A, Mazumdar M, et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005;12(5):347–53.
Mariette C, Piessen G, Lamblin A, et al. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg. 2006;93(9):1077–83.
Dexter SP, Sue-Ling H, McMahon MJ, et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001;48(5):667–70.
Sagar PM, Johnston D, McMahon MJ, et al. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg. 1993;80(11):1386–8.
Hosokawa Y, Kinoshita T, Konishi M, et al. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert’s classification after radical resection. Anticancer Res. 2014;34:4391–8.
Zhang WH, Chen XZ, Liu K, et al. Comparison of the clinicopathologic characteristics and the survival outcomes between the Siewert II/III adenocarcinomas. Med Oncol. 2014;31:116–24.
Meier I, Merkel S, Papadopolous T, et al. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic volume definition. Int J Radiat Oncol Biol Phys. 2008;70:1408–17.
Fujitani K, Miyashiro I, Mikata S, et al. Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert Type II adenocarcinoma of the cardia: results of a multicenter study. Gastric Cancer. 2013;16:301–8.
Hasegawa S, Yoshikawa T, Rini Y, et al. Priority of lymph node dissection for Siewert II/III adenocarcinoma of the esophagogastric junction. Ann Surg Oncol. 2013;20:4252–9.
Hulscher J, van Sandick J, DeBoer A, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–9.
Biere Y, Henegouwen M, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomized controlled trial. Lancet. 2012;379:1887–92.
Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46–50.
Migliore M, Rassl D, Criscione A. Longitudinal and circumferential resection margin in adenocarcinoma of the distal esophagus and cardia. Future Oncol. 2014;10:891–901.
Sasaki M, Sano T, Yamamoto S, et al. Left thoracoabdominal versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomized controlled trial. Lancet Oncol. 2006;7:644–51.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rizk, N. Gastroesophageal Junction Tumors. Ann Surg Oncol 23, 3798–3800 (2016). https://doi.org/10.1245/s10434-016-5427-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-016-5427-5